A high content clonogenic survival drug screen identifies MEK inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer

Steven H. Lin, Jing Zhang, Uma Giri, Clifford Stephan, Mary Sobieski, Ling Zhong, Kathy A. Mason, Jessica Molkentine, Howard D. Thames, Stephen S. Yoo, John V. Heymach

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A high content clonogenic survival drug screen identifies MEK inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences